Cigna Group

Cigna Group is a U.S.-based global health company that combines health benefits and pharmacy/medical services through two core segments: Cigna Healthcare and Evernorth Health Services. It serves employers, health plans, government-related programs, and individuals with medical coverage, pharmacy benefit management, specialty pharmacy, care management, and related health solutions.

4,4 %

21,8 %

2,2 %

+11,2 %

0.85

0.72

— Cigna Group
%
Evernorth Health Services55% Pharmacy benefit, specialty pharmacy, care management, and related health solutions.
Cigna Healthcare40% Medical benefit plans and coordinated health solutions for U.S. and international customers.
Other Operations5% Run-off and non-strategic businesses not part of the core operating segments.

Cigna sells primarily to employers, unions, third-party administrators, health plans, and government-related customers,...

  • Employer groupsprimary

    Middle, select, and small employers buy medical and pharmacy benefits for employees and dependents.

  • Managed care and health plan clientsprimary

    Health insurers, TPAs, and managed care organizations buy PBM and care services to lower cost and improve outcomes.

  • Individualssecondary

    Individuals buy ACA exchange, individual, and other insured products for personal coverage needs.

  • International employers and expatriatessecondary

    Multinational employers and globally mobile individuals buy international health coverage and support.

  • Government-related and senior populationssecondary

    Medicare-related customers and government programs were served historically, though some businesses were sold in 2025.

Cigna operates globally, with the United States as its core market and international health activity across more than...

  • •United States is the main market for medical and pharmacy benefits
  • •International Health spans more than 30 markets and jurisdictions
  • •U.S. provider network includes about 1.7 million physicians and 6,000+ hospitals
  • •International expansion increases regulatory, currency, and compliance exposure
  • •No country-level revenue split was disclosed in the excerpts provided

Cigna’s strategy centers on integrating pharmacy and medical capabilities to improve affordability, transparency, and...

01
Integrate medical and pharmacy offeringsmedium-term

Cross-selling and coordination improve customer value and deepen retention.

02
Expand specialty pharmacy and care servicesmedium-term

Specialty utilization and care management are major growth and margin drivers.

03
Improve affordability and contract economicsshort-term

Better pricing and claims composition support competitiveness and margins.

04
Simplify the portfolio and exit non-core assetsshort-term

Divestitures reduce complexity and focus capital on core health services.

Cigna’s earnings are exposed to medical cost trend, pharmacy utilization, pricing pressure, and the ability to manage...

high

Medical cost inflation and utilization pressure

Premiums and fees may not keep pace with higher claims and service usage.

Scope
Cigna Healthcare
Materiality
high
high

Pricing competition and margin compression

Health plans and PBM services are competitive and can face contract repricing.

Scope
Evernorth Health Services and Cigna Healthcare
Materiality
high
high

Operational and supply-chain disruption

Claims processing, home delivery, and pharmacy fulfillment depend on uninterrupted systems and vendors.

Scope
Express Scripts, Accredo, home delivery, call centers
Materiality
high
medium

International regulatory and geopolitical exposure

Foreign operations require compliance with local laws, data rules, and anti-corruption regimes.

Scope
International Health
Materiality
medium
medium

Goodwill and intangible asset impairment

Acquisitions and portfolio changes create large balance-sheet intangibles sensitive to forecast revisions.

Scope
Reporting units and acquired businesses
Materiality
medium
Medical claims and premium adequacy estimates
Affects medical care ratio and segment margins
Adjusted revenues and segment reporting
Impacts comparability across periods and segments
Goodwill and intangible asset impairment
Could create material non-cash charges
Held-for-sale and divestiture accounting
Changes reported revenue and earnings mix

CIENA CORP

CIEN · Telephone & Telegraph Apparatus

Cencora, Inc.

COR · Wholesale-Drugs, Proprietaries & Druggists' Sundries

CENTENE CORP

CNC · Hospital & Medical Service Plans

AMGEN INC

AMGN · Biological Products, (No Diagnostic Substances)

Sionna Therapeutics, Inc.

SION · Pharmaceutical Preparations

SIGA TECHNOLOGIES INC

SIGA · Pharmaceutical Preparations

: 11/08/2026